Central Florida Cardiac & Vascular Institute Announces New Implant to Treat Heart Failure and Sudden
Central Florida Cardiac & Vascular Institute of Osceola Regional Medical Center announced one of Central Florida’s first and newest Boston Scientific defibrillator implanted on February, 17, 2012. The implant of the next generation of the implantable cardioverter defibrillator (ICD) was performed by Naushad Shaik, M.D., Cardiologist and Electrophysiologist affiliated with Osceola Regional Medical Center and its Cardiac & Vascular Institute. This will also be one of the first in HCA hospitals to implant this new Boston Scientific device.
The ENERGEN DF-4 device is one of the latest Boston Scientific FDA approved collection of high-energy and smallest devices to treat heart failure and sudden cardiac death. Central Florida patients and physicians can now benefit from its enhanced therapy options, advanced battery longevity with a backup warranty of 10 years and a DF4 universal connector system in the industry’s smallest and thinnest platform.
“Creating longer-lasting devices is simply the right thing to do for the patients,” said Naushad Shaik, M.D. “It benefits those who are living longer due to advances in device therapy, those who are receiving devices earlier in their lives based on our clinical science and those who need more frequent device changes because of their clinical condition.”
Caption: Naushad Shaik, M.D.